EMRYX | FWWNX | EMRYX / FWWNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 4 years | - |
Gain YTD | 1.186 | 1.070 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 397M | 62.6B | 1% |
Annual Yield % from dividends | 1.55 | 1.50 | 103% |
Returns for 1 year | 4.63 | 7.36 | 63% |
Returns for 3 years | -12.30 | -1.82 | 677% |
Returns for 5 years | -22.02 | N/A | - |
Returns for 10 years | 5.92 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DWOCX | 16.01 | 0.17 | +1.07% |
BNY Mellon Research Growth C | |||
FECMX | 38.54 | 0.40 | +1.05% |
Fidelity Advisor Emerging Markets I | |||
NEMAX | 19.87 | 0.18 | +0.91% |
Neuberger Berman Emerg Mkts Eq A | |||
AWWIX | 13.00 | 0.08 | +0.62% |
CIBC Atlas International Growth Instl | |||
CLTCX | 14.90 | 0.09 | +0.61% |
Catalyst/Lyons Tactical Allocation C |